ARCHIVES

Contracts Cutback Canceled 7 RFPs

This article is from The Cancer Letter archive.

Vol. 06 No. 32 | August 8, 1980

Download PDF Visit The Full Archive

Related Articles

Gallo Actively Searching For New Position

July 1, 1994

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

May 30, 2008

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009